September 11, 2017 / 8:06 AM / 12 days ago

BRIEF-Teva Pharm chairman: Schultz has credibility with stakeholders

Sept 11 (Reuters) - Teva Pharmaceutical Industries :

* Chairman: Kare Schultz hit all criteria, has significant credibility with stakeholders

* Chairman: “no plans now” to separate generic, speciality drugs businesses

* Chairman: we need to restore credibility among investors, will continue divesting non-core assets Further company coverage: (Reporting by Steven Scheer; Editing by Tova Cohen)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below